Press News

Press News

Press News | 18.02.2025

Print:
Title Media Publ. Date
It started 2025 with a surplus of 2 billion Apogevmatini 18/02/2025
4 out of 10 want the EU to prioritize tackling high prices Efsyn 18/02/2025
Increase in contribution caps to professional insurance funds Kathimerini 18/02/2025
Voluntary price reduction by PHARMASERVE-LILLY Naftemporiki 18/02/2025
The budget for diabetes is causing strong reactions Naftemporiki 18/02/2025

 

See here the publicity

 

Web Monitoring Report for the period 17/02- 18/02

Title Media Publ. Date
Cutting-edge alliance of Greece – Cyprus in pharmaceutical policy and medical education cnn.gr 17/02/2025
Korina Pateli – Bell: “We are companions of people living with lung cancer through action, empathy, and results” healthmag.gr 17/02/2025
WHO: The urgent need for a joint response to pandemics healthpharma.gr 18/02/2025
Restrictions everywhere on medicines, tests, and private clinics – The plan to reduce expenditures healthreport.gr 18/02/2025
Medicine: Breaking expenditure in the private market faces obstacles – What actions will EOPYY take? iatronet.gr 18/02/2025
Online Pharmacies: They are thriving in Greece iatropedia.gr 18/02/2025
The savings for the hospital clawback of 2023 stand at 5% in.gr 18/02/2025
Hospital clawback: The 2nd round of notes for 2023 begins – What remains uncertain? insider.gr 18/02/2025
The development of new medicines in oncology and their licensing process news247.gr 17/02/2025
The notes for exceeding the 2023 hospital expenditure are coming news4health.gr 17/02/2025
Public pharmaceutical expenditure: Greece’s “exception” justifies many of its shortcomings parapolitika.gr 18/02/2025
IFET: The subsidiary of EOF that fills the gaps in patient care for rare diseases tovima.gr 17/02/2025

RELATED NEWS

Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.